Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus propofol for hemodynamic stability during cervical dilatation and hysteroscopy
ChiCTR2200065624Phase 4Recruiting
- Sponsor
- Fuzhou Jin'an District Hospital
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam, propofol and lidocaine in dilatation and curettage and None (6 arms), sponsored by Fuzhou Jin'an District Hospital. Primary endpoints: Vital signs and Acetylcholine. Started Nov 2022; status: recruiting.
02
Drugs
remimazolampropofollidocaine
03
Conditions
dilatation and curettage
Beyond the preview
Go deeper on ChiCTR2200065624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200065624.